YOLFTbeta
Harbin Pharmaceutical Group Co Ltd

Harbin Pharmaceutical Group Co Ltd

600664 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

5.17CNY-0.51 (-8.98%)

Price History

Full chart

Market Stats

Previous Close5.68
Open5.67
Day Range5.15 – 5.67
52-Week Range2.84 – 9.86
Volume330.21M
Market Cap18.64B
P/E (TTM)37.00
Forward P/E20.16
EPS0.20
Dividend Yield0.00%
Beta0.02
50-Day Avg7.64
200-Day Avg4.57

About

Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, antiviral and anti-infective, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supplements, and antibiotics. It also provides calcium iron zinc oral solutions, zinc gluconate oral solutions, compound calcium gluconate oral solutions, Shuanghuanglian oral solutions, amoxicillin capsules, human erythropoietin injections, iron and vitamin B12 oral solutions, calcium, iron, and zinc oral solutions, ceftriaxone sodium injections, Qufenggutong gel ointment, GNC Vitapak nutritional pack, lacidipine tablets, GNC fish oil capsules, coenzyme Q10 and panthenol soft capsules, GNC children's liquid calcium magnesium zinc, penicillin sodium, acetaminophen and chlorpheniramine maleate granules, glucosamine chondroitin calcium tablets, ceftriaxone sodium for injection, GNC milk thistle extract tablets and capsules, and compound sulfamethoxazole oral tablets. The company is also involved in culture, science and technology, pharmaceutical commercial and industry, property, and investment activities. Harbin Pharmaceutical Group Co., Ltd. was founded in 1991 and is based in Harbin, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Chuanyou Lu
  • Employees10.04K
  • HeadquartersNo. 7, Qunli Avenue, Harbin, China, 150070, China
  • Websitehttps://www.hayao.com

Leadership

  • Mr. Chuanyou LuPresident & Director · b. 1962
  • Mr. Xiaodong MengVP, Secretary & Financial Director · b. 1972
  • Mr. Haitao JiangVice President · b. 1982
  • Mr. Jicheng XiaVice President · b. 1979
  • Mr. Bangdong LiVice President · b. 1973
  • Mr. Guangjun DiaoVice President · b. 1976

Financials

Income Statement

Currency: CNY1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.35B1.76B2.04B2.18B2.27B2.92B4.49B6.44B5.37B6.51B6.93B7.17B8.49B9.27B8.29B9.70B10.68B12.54B13.41B17.66B18.09B16.51B15.86B14.13B12.02B10.81B11.82B10.79B12.80B13.81B15.46B16.18B15.96B
Growth (%)--25.01%+15.76%+7.21%+4.10%+28.69%+53.41%+43.63%-16.70%+21.36%+6.35%+3.55%+18.38%+9.12%-10.55%+16.95%+10.13%+17.40%+7.01%+31.68%+2.43%-8.75%-3.95%-10.91%-14.93%-10.02%+9.35%-8.76%+18.66%+7.86%+11.93%+4.65%-1.31%
Cost of Revenue1.71B-1.50B1.61B1.68B2.19B2.77B3.16B3.11B4.09B4.11B4.49B5.39B6.02B5.57B6.59B7.26B8.80B10.33B12.05B12.95B12.04B11.98B10.43B8.91B7.92B9.03B8.54B9.83B10.45B11.44B11.66B11.82B
Gross Profit634.33M1.76B540.54M575.11M592.90M734.89M1.71B3.28B2.26B2.43B2.82B2.69B3.11B3.20B2.72B3.10B3.42B3.74B3.16B5.61B5.14B4.47B3.88B3.70B3.11B2.90B2.80B2.25B2.98B3.36B4.01B4.52B4.15B
Gross Margin27.04%100.00%26.54%26.34%26.09%25.13%38.16%50.90%42.14%37.23%40.67%37.47%36.59%34.57%32.78%32.00%31.99%29.83%23.57%31.77%28.40%27.06%24.44%26.20%25.89%26.78%23.67%20.81%23.24%24.35%25.97%27.95%25.98%
Operating Expense473.12M1.64B409.52M444.36M452.72M580.91M1.50B2.95B1.86B2.01B2.35B2.33B2.36B2.46B2.10B2.13B2.40B2.57B2.62B4.71B4.90B4.13B3.13B2.70B2.46B2.37B2.52B3.19B2.33B2.67B3.35B3.63B3.42B
Operating Income161.20M116.56M131.02M130.74M140.18M153.99M215.68M333.92M399.73M417.93M472.27M356.15M748.39M747.86M616.57M973.26M1.01B1.17B538.98M898.27M237.98M340.10M741.31M997.15M655.90M527.37M277.74M-942.11M642.41M695.80M659.63M890.20M730.51M
Operating Margin6.87%6.63%6.43%5.99%6.17%5.26%4.81%5.18%7.45%6.41%6.82%4.96%8.81%8.07%7.44%10.04%9.47%9.34%4.02%5.09%1.32%2.06%4.68%7.06%5.46%4.88%2.35%-8.73%5.02%5.04%4.27%5.50%4.58%
EBITDA243.18M1.76B234.09M227.84M229.25M335.19M434.67M548.87M637.39M702.71M791.95M713.41M1.09B1.12B1.04B1.43B1.41B1.66B932.43M1.30B619.72M795.22M1.21B1.41B984.50M882.28M550.35M-433.54M716.99M821.32M878.27M1.07B924.41M
EBITDA Margin10.37%100.00%11.50%10.44%10.09%11.46%9.69%8.52%11.87%10.79%11.43%9.94%12.88%12.11%12.59%14.80%13.20%13.26%6.95%7.38%3.43%4.82%7.66%9.96%8.19%8.16%4.65%-4.02%5.60%5.95%5.68%6.59%5.79%
Net Income137.44M100.91M109.21M112.44M120.63M97.62M138.70M217.61M283.80M301.84M331.37M262.96M456.15M467.32M591.81M862.32M932.93M1.13B578.66M499.65M168.67M247.11M580.13M788.10M406.98M346.14M55.81M-1.08B371.08M465.15M395.26M628.85M361.60M
Net Income Margin5.86%5.74%5.36%5.15%5.31%3.34%3.09%3.38%5.29%4.63%4.78%3.67%5.37%5.04%7.14%8.89%8.74%9.02%4.31%2.83%0.93%1.50%3.66%5.58%3.39%3.20%0.47%-9.99%2.90%3.37%2.56%3.89%2.27%
R&D-----------------233.04M263.07M223.29M251.17M251.35M194.84M177.77M142.13M137.26M125.14M92.53M97.73M115.81M106.02M136.43M145.01M
R&D as % of Total Revenue-----------------1.86%1.96%1.26%1.39%1.52%1.23%1.26%1.18%1.27%1.06%0.86%0.76%0.84%0.69%0.84%0.91%
Interest Expense86.13M-104.79M106.45M92.23M96.43M35.38M45.06M56.22M53.02M45.90M55.77M67.55M46.49M65.12M25.19M4.43M4.56M3.43M24.93M18.16M9.70M10.73M6.90M22.17M30.26M51.86M64.72M112.72M99.48M69.44M68.39M42.55M
Interest Expense % of Total Revenue3.67%-5.15%4.88%4.06%3.30%0.79%0.70%1.05%0.81%0.66%0.78%0.80%0.50%0.79%0.26%0.04%0.04%0.03%0.14%0.10%0.06%0.07%0.05%0.18%0.28%0.44%0.60%0.88%0.72%0.45%0.42%0.27%

Balance Sheet

Currency: CNY1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.24B2.35B2.40B2.49B2.90B3.62B4.41B4.45B5.77B5.95B6.58B7.49B8.63B9.40B9.45B9.68B10.01B11.76B11.66B15.67B16.46B16.24B13.77B15.05B13.70B11.90B12.50B11.85B12.84B13.44B14.11B14.62B14.29B
Total Liabilities1.64B1.71B1.73B1.70B1.78B2.34B2.94B2.82B3.09B3.08B3.45B3.59B4.24B4.43B4.40B3.89B4.02B5.22B5.25B7.02B7.68B7.47B6.28B6.75B6.22B5.62B6.56B7.86B8.42B8.48B8.69B8.53B7.83B
Total Equity592.10M634.61M668.14M784.98M1.11B1.27B1.47B1.61B2.65B2.81B3.04B3.38B3.85B4.34B5.05B5.79B5.98B6.51B6.38B7.96B8.15B8.24B7.05B7.85B7.05B5.87B5.46B3.48B3.85B4.33B4.72B5.35B5.69B
Cash51.23M85.68M67.08M74.85M121.28M186.29M499.83M323.65M1.03B956.78M787.49M664.98M1.12B1.35B2.11B1.56B1.98B2.49B1.57B2.02B1.76B2.33B1.82B4.64B3.51B2.05B675.50M897.00M1.59B2.43B3.06B3.63B3.44B
Total Debt1.04B1.06B1.03B986.28M958.14M1.27B1.08B990.61M982.55M972.22M1.05B1.44B1.50B997.24M1.65B966.85M161.46M158.18M158.83M419.96M188.13M164.73M197.65M148.29M262.20M254.18M673.08M1.77B2.31B2.16B1.72B1.62B-
Net Debt992.63M976.21M959.78M911.43M836.85M1.09B576.34M666.96M-50.01M15.44M259.10M770.49M374.04M-349.51M-462.23M-596.82M-1.82B-2.33B-1.41B-1.60B-1.58B-2.17B-1.62B-4.49B-3.25B-1.79B-2.42M876.71M720.94M-276.43M498.52M-2.01B-

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow221.41M431.22M541.70M604.13M383.44M302.83M149.01M757.76M738.08M650.16M578.59M1.85B1.15B-31.56M557.83M141.64M1.14B1.66B2.78B149.22M692.72M-284.94M-728.15M-162.44M622.09M949.67M792.50M439.66M
Investing Cash Flow-69.78M-175.38M-563.57M-702.70M-390.57M-468.98M-425.82M-265.52M-391.83M-378.94M-457.46M165.70M-52.10M-127.40M-309.65M-297.59M-384.86M-284.44M-76.37M-67.98M-804.11M-1.37B-101.17M91.62M72.34M-206.64M-98.91M-
Financing Cash Flow-86.63M57.70M-154.31M807.49M-68.40M-3.14M153.61M-34.96M-119.76M492.09M-667.52M-1.60B-592.50M-763.04M-187.65M-146.58M-153.41M-1.89B114.00M-1.21B-1.36B287.53M1.06B393.26M174.62M147.94M-125.61M-
Capital Expenditure100.73M184.43M582.49M635.28M391.03M473.73M428.60M443.61M326.28M175.00M143.09M223.26M299.19M233.63M275.78M369.90M375.37M290.75M107.46M102.01M114.11M39.00M118.21M76.70M89.65M86.54M100.81M150.95M
Free Cash Flow120.69M246.79M-40.80M-31.15M-7.59M-170.89M-279.59M314.15M411.81M475.17M435.50M1.63B853.47M-265.19M282.05M-228.26M760.73M1.37B2.67B47.21M578.61M-323.94M-846.37M-239.13M532.45M863.14M691.69M288.71M
Dividends Paid22.04M69.45M81.55M118.34M79.23M86.27M108.68M87.17M33.07M58.28M96.62M795.70M589.68M762.17M25.23M8.25M144.38M1.92B83.53M1.35B1.35B10.34M24.10M61.55M54.30M44.16M47.11M33.29M
FCF to OCF54.51%57.23%-7.53%-5.16%-1.98%-56.43%-187.64%41.46%55.79%73.08%75.27%87.94%74.04%840.17%50.56%-161.15%66.96%82.48%96.13%31.64%83.53%113.69%116.23%147.22%85.59%90.89%87.28%65.67%
Dividend Paid to FCF18.26%28.14%-199.89%-379.93%-1044.42%-50.48%-38.87%27.75%8.03%12.26%22.19%48.87%69.09%-287.40%8.94%-3.61%18.98%140.56%3.13%2850.94%233.47%-3.19%-2.85%-25.74%10.20%5.12%6.81%11.53%

Earnings

Report DateMar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007May 28, 2008Sep 3, 2008Dec 3, 2008Feb 25, 2009Jun 3, 2009Sep 2, 2009Oct 30, 2009Mar 3, 2010Apr 30, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 29, 2014Oct 16, 2014Feb 6, 2015Apr 29, 2015Aug 30, 2015Oct 30, 2015Feb 5, 2016Apr 29, 2016Aug 18, 2016Oct 30, 2016Mar 3, 2017Apr 16, 2017Aug 9, 2017Oct 26, 2017Feb 9, 2018Apr 16, 2018Aug 15, 2018Oct 30, 2018Mar 16, 2019Apr 23, 2019Aug 31, 2019Oct 26, 2019Apr 28, 2020Aug 26, 2020Oct 30, 2020Apr 28, 2021Aug 27, 2021Oct 29, 2021Apr 28, 2022Aug 26, 2022Oct 27, 2022Apr 28, 2023
EPS Estimate----------0.12-0.12-----------------0.02-0.060.02-0.02-------0.160.130.10-----------------
EPS Actual0.040.060.050.140.070.110.120.120.110.110.120.100.100.140.130.140.150.160.10-0.14-0.010.060.060.090.09-0.020.03-0.040.070.060.00-0.030.070.090.010.070.040.110.090.070.020.10-0.040.040.060.08-0.050.04-0.060.040.02-0.07-0.06-0.02-0.280.100.06-0.050.010.010.12
Surprise----------0.00%--16.67%----------------400.00%103.50%-250.00%-350.00%--------37.50%-130.77%-60.00%-----------------
Timing----------Pre-market-Pre-market----------------After-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hours-------------Pre-market--After-hours

Key Statistics & Ratios

Market Cap18.64B
Enterprise Value20.70B
Trailing P/E37.00
Forward P/E20.16
Price / Sales1.16
Price / Book3.73
EPS0.20
Book Value2.42
Revenue (TTM)16.14B
Gross Profit (TTM)4.10B
EBITDA884.50M
Profit Margin3.18%
Operating Margin6.43%
Return on Equity8.22%
Return on Assets2.92%
Shares Outstanding2.52B
Shares Float1.31B
Beta0.02
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20181×
0.50May 4, 2018
20171×
0.50Apr 13, 2017
20151×
0.77Nov 13, 2015
20141×
0.05Aug 26, 2014
20111×
0.45Aug 1, 2011
20101×
0.29Jun 9, 2010
20091×
0.35Jul 27, 2009
20081×
0.06Jul 31, 2008
20041×
0.06Aug 13, 2004
20031×
0.05Jul 17, 2003
20021×
0.03Jul 12, 2002
20011×
0.04Jun 15, 2001
20001×
0.03Jul 25, 2000
19981×
0.03Jun 22, 1998
19961×
0.03Aug 29, 1996

Stock Splits

  • Apr 6, 201693773:72133
  • Aug 1, 201113:10
  • Aug 13, 200413:10
  • Jul 17, 20033:2
  • Jul 12, 20026:5
  • Mar 8, 19991249:1185
  • Jul 29, 1997615:569
  • Apr 24, 199713:10